Xiaobo Li

机构：Shanxi Medical University, Renji Hospital, Moffitt Cancer Center, Shanxi University of Traditional Chinese Medicine · ORCID：0000-0003-4350-5976

发表论文 233 篇 · 总被引 8576 次 · h-index 51

代表论文

• Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis (2025 · Nature Communications · 被引 26)
• STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development (2025 · Cancer Letters · 被引 21)
• Material intelligence by the convergence of artificial intelligence and robotic platforms (2025 · Nexus · 被引 12)
• CD160 dictates anti-PD-1 immunotherapy resistance by regulating CD8+ T cell exhaustion in colorectal cancer (2025 · Nature Cell Biology · 被引 7)
• Rapid and sensitive acute leukemia classification and diagnosis platform using deep learning-assisted SERS detection (2025 · Cell Reports Medicine · 被引 6)
• ‘Cell knife’ for cancer: the clinician’s perspective (2025 · Frontiers in Immunology · 被引 5)